FDA Hold on Embryonic Stem Cell Experiments
by David Prentice
October 2, 2009
Speaking of clinical trials, in case you missed it the FDA has put another hold on Geron’s proposed experiments to put embryonic stem cells into human spinal cord injury patients. Geron’s human experiment was approved back in January 2009, and they were supposed to start experiments with patients in July.
As an aside, one excuse offered by Geron as to why the trial had not yet started was car airbags… apparently the airbags in accidents are keeping patients from getting severe spinal cord damage to qualify for the trial.
Many have expressed concern about the risky nature of Geron’s experiments with patients, including some embryonic stem cell researchers. Evan Snyder, a leader in the stem cell field, has noted that “A clinical trial is nothing more than an experiment on a human,” he says. “Most experiments fail.” And James Wilson, gene therapy researcher, warns stem cell scientists not to repeat the mistakes of his own field, including rushing into unsafe clinical trials.
The FDA hold is likely due to further safety concerns with embryonic stem cells. That would seem to be the only grounds for a hold based on federal regulations under CFR sec. 312.42. Geron claims that no teratomas have been observed in animal studies, though they do admit “In some animals, human non-neural differentiated cell types were observed in the injury site”. After the current FDA hold was iissued, Geron put out a statement explaining that cysts developed at the injury sites of treated animals, and they are working with FDA to answer any questions. They claim no teratomas have been seen, and hopefully nothing like this.
Still, there is cause for concern. Dr. Steven Goldman says
“It’s not ready for prime time, at least not in my mind, until we can be assured that the transplanted stem cells have completely lost the capacity for tumorigenicity.”
But with the political pressure in favor of embryonic stem cell research, the hold will likely be release and the experiments on patients move ahead. And Geron will likely claim success (to get another stock bump.) Despite the fact that adult stem cells have already shown documented evidence not only of their safety, but of their efficacy at treating spinal cord injury.
Evidence of adult stem cell success for spinal cord injury patients has already been published by groups in Portugal, Australia, and Ecuador. Adult stem cells–real hope and help now.
Family Research Council is a 501c(3) non-profit organization. If this post has been helpful to you, please consider a gift to help us continue to advance Faith, Family, and Freedom.
Comments
adult stem cells are not pluripotent, meaning they cannot change into any cell in the body.
while transplanting adult spinal cells may help some, it doesn’t have near the potential that embryonic stem cells have… it’s just more of the same
The author doesn’t forget to lie at the end when he says that adult stem cells have already shown evidence of success for spinal cord injuries. The evidence would’ve been provided if that was true. It, however, is not. No one has regained any function from a stem cell treatment offered abroad. The only real evidence of recovery from spinal cord injury after a stem cell based therapy has been in the United States. And that was done with embryonic stem cells on animal models by Dr. Hans Keirstead at UC Reeve Irvine.
Matt–
You must have skipped over the reference links at the end; the published evidence WAS provided.
As far as animal studies, see http://www.stemcellresearch.org/facts/ASCRvESCRSpinalCord.pdf
[...] but before a single desperate patient had been injected with the potentially-dangerous cells, the FDA placed a hold on the Geron experiment due to safety [...]
[...] So much for science trumping politics. In terms of real science, and patients, Geron was put on hold again by the FDA due to safety concerns. [...]

By: FRC Blog » NIH Director Ignorant On Stem Cells? | October 2, 2009 at 5:27 pm
[...] What?!? The “one clinical trial” Collins refers to is the one embryonic stem cell experiment with patients that is out there. And it is indeed on hold. [...]